This webinar addresses basic questions regarding the development of antiviral drugs and vaccines for COVID-19 and correct some misinformation that has appeared in the popular media. The presentation includes discussions of the process of antiviral and vaccine development, design of clinical trials, requirements for FDA approval of therapeutics, and current therapeutic initiatives.

Speakers
Fred Krebs, Ph.D.
Professor, Microbiology & Immunology
Director, Infectious Disease Program
Co-Director, Division of Interdisciplinary and Career-oriented Programs

Paul McGonigle, Ph.D.
Professor, Pharmacology & Physiology
Director, Drug Discovery & Development
Co-Director, Division of Interdisciplinary and Career-oriented Programs

Sonia Navas-Martin, Ph.D.
Associate Professor, Microbiology & Immunology

Michele Kutzler, Ph.D.
Associate Professor, Medicine, Microbiology & Immunology
Assistant Dean of Faculty Development

Richard Mangano, Ph.D.
Associate Professor
Director, Clinical Research Program

#COVID19 #Coronavirus #Therapeutics